Subscribe to Money Morning get daily headlines subscribe now! Money Morning Private Briefing today's private briefing Access Your Profit Alerts

Akari Therapeutics (NASDAQ: AKTX)

$6.61 USD -$0.08 (-1.20%)
Last Price $6.61
Net Change $-0.08 (-1.2%)
Bid $0
Ask Price $0
Open Price $6.86
Previous Close Price $6.69
High Price $6.89
Low Price $6.55
Number of Trades 120
Volume 26,300
Fifty Two Week High $22.2 (2017-04-10)
Fifty Two Week Low $6.22 (2017-03-24)
Average Daily Volume 523,852
Share Outstanding 11,780 Shares
Total Dividend Payout 0/yr
Dividend Yield 0%
1st Quarter Earnings $ ()
2nd Quarter Earnings $ ()
3nd Quarter Earnings $ ()
4th Quarter Earnings $ ()
PE Ratio $0
EPS Growth $-940
Recent Earnings $
Annual EPS $-0.5
Last Quarter EPS $
Market Capitalization $0.08B
Insider Shareholders % 0.618%
Annual Revenue $0B
No. Shares Outstanding 11,780
Inst. Shareholder % 30.01%
Annual Net Income $-0.03B
TTM Net Profit Margin $0
1-Year Return -54.54%
3-Year Return -87.69%
5-Year Return -50.3%
5-Year Revenue Growth 0%
5-Year Earnings Growth 0%
5-Year Dividend Growth 0%
Annual Dividend $0
Annual Dividend Yield 0%
Change in EPS YTD -940%
Dividends per Share $
Stock Split Ratio 1-10
Beta -9.46
Akari Therapeutics PLC is a biopharmaceutical company. It focused on the development and commercialization of innovative therapeutics to treat orphan autoimmune and inflammatory diseases. The Company's lead drug consist of Coversin is a recombinant small protein, which acts on complement component-C5, preventing release of C5a and formation of C5b-9. Akari Therapeutics PLC, formerly known as Celsus Therapeutics Plc, is based in London, United Kingdom.

AKTX News & Stock Updates